# Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)

> **NCT07449325** · NA · RECRUITING · sponsor: **VahatiCor, Inc.** · enrollment: 30 (estimated)

## Conditions studied

- Angina Pectoris
- Myocardial Ischemia
- Heart Diseases
- Cardiovascular Diseases
- Vascular Diseases
- Microvascular Angina

## Interventions

- **DEVICE:** A-FLUX Reducer System

## Key facts

- **NCT ID:** NCT07449325
- **Lead sponsor:** VahatiCor, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2026-11
- **Final completion:** 2027-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07449325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07449325, "Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)". Retrieved via AI Analytics 2026-07-24 from https://api.ai-analytics.org/clinical/NCT07449325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*